GL1X · GenesisL1 explorer

MolNFT v2 · #101747 · protein

Identification of novel HSP90/isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington's disease

MolNFT v2 record #101747 on GenesisL1: PDB 4O07, “Identification of novel HSP90/isoform selective inhibitors using structure-based drug design. Demonstration of…”. Protein, 209 residues. 3D structure, sequence proof, BLAST and…

PDB
4O07
Type
protein
Length
209 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.